2LU4

Solution NMR structure of the beta2 carbohydrate module of AMP-activated protein kinase bound to glucosyl-cyclodextrin

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D CBCA(CO)NH	0.7 mM [U-98% 13C; U-98% 15N] protein, 50 mM sodium phosphate, 2.5 mM glucosyl-cyclodextrin, 0.02 % sodium azide	90% H2O/10% D2O	0.05	6.9	ambient	298
2	3D HNCACB	0.7 mM [U-98% 13C; U-98% 15N] protein, 50 mM sodium phosphate, 2.5 mM glucosyl-cyclodextrin, 0.02 % sodium azide	90% H2O/10% D2O	0.05	6.9	ambient	298
3	3D HNCO	0.7 mM [U-98% 13C; U-98% 15N] protein, 50 mM sodium phosphate, 2.5 mM glucosyl-cyclodextrin, 0.02 % sodium azide	90% H2O/10% D2O	0.05	6.9	ambient	298
4	3D HBHA(CO)NH	0.7 mM [U-98% 13C; U-98% 15N] protein, 50 mM sodium phosphate, 2.5 mM glucosyl-cyclodextrin, 0.02 % sodium azide	90% H2O/10% D2O	0.05	6.9	ambient	298
5	3D H(CCO)NH	0.7 mM [U-98% 13C; U-98% 15N] protein, 50 mM sodium phosphate, 2.5 mM glucosyl-cyclodextrin, 0.02 % sodium azide	90% H2O/10% D2O	0.05	6.9	ambient	298
6	3D C(CO)NH	0.7 mM [U-98% 13C; U-98% 15N] protein, 50 mM sodium phosphate, 2.5 mM glucosyl-cyclodextrin, 0.02 % sodium azide	90% H2O/10% D2O	0.05	6.9	ambient	298
7	3D HCCH-TOCSY	0.7 mM [U-98% 13C; U-98% 15N] protein, 50 mM sodium phosphate, 2.5 mM glucosyl-cyclodextrin, 0.02 % sodium azide	100% D2O	0.05	6.9	ambient	298
8	2D 1H-1H TOCSY	0.7 mM protein, 50 mM sodium phosphate, 2.5 mM glucosyl-cyclodextrin, 0.02 % sodium azide	100% D2O	0.05	6.9	ambient	298
9	2D 1H-1H NOESY	0.7 mM protein, 50 mM sodium phosphate, 2.5 mM glucosyl-cyclodextrin, 0.02 % sodium azide	100% D2O	0.05	6.9	ambient	298
10	3D 1H-15N NOESY	0.7 mM [U-98% 15N] protein, 50 mM sodium phosphate, 2.5 mM glucosyl-cyclodextrin, 0.02 % sodium azide	90% H2O/10% D2O	0.05	6.9	ambient	298
11	3D 1H-13C NOESY aliphatic	0.7 mM [U-98% 13C; U-98% 15N] protein, 50 mM sodium phosphate, 2.5 mM glucosyl-cyclodextrin, 0.02 % sodium azide	100% D2O	0.05	6.9	ambient	298
12	3D HNHA	0.7 mM [U-98% 15N] protein, 50 mM sodium phosphate, 2.5 mM glucosyl-cyclodextrin, 0.02 % sodium azide	90% H2O/10% D2O	0.05	6.9	ambient	298
13	3D HNHB	0.7 mM [U-98% 15N] protein, 50 mM sodium phosphate, 2.5 mM glucosyl-cyclodextrin, 0.02 % sodium azide	90% H2O/10% D2O	0.05	6.9	ambient	298
14	3D HACAHB-COSY	0.7 mM [U-98% 13C; U-98% 15N] protein, 50 mM sodium phosphate, 2.5 mM glucosyl-cyclodextrin, 0.02 % sodium azide	100% D2O	0.05	6.9	ambient	298
15	2D 1H-15N HSQC	0.7 mM [U-98% 15N] protein, 50 mM sodium phosphate, 2.5 mM glucosyl-cyclodextrin, 0.02 % sodium azide	90% H2O/10% D2O	0.05	6.9	ambient	298
16	3D13C,15N-filtered,edited NOESY	0.7 mM [U-98% 13C; U-98% 15N] protein, 50 mM sodium phosphate, 2.5 mM glucosyl-cyclodextrin, 0.02 % sodium azide	100% D2O	0.05	6.9	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	800
2	Bruker	AVANCE	600

NMR Refinement
Method	Details	Software
torsion angle dynamics		CYANA

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure solution	CYANA	2.1	Guntert, Mumenthaler and Wuthrich
2	refinement	CYANA	2.1	Guntert, Mumenthaler and Wuthrich
3	chemical shift assignment	Sparky		Goddard
4	peak picking	Sparky		Goddard
5	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
6	data analysis	TALOS		Cornilescu, Delaglio and Bax

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.